We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
GLOBETECH PUBLISHING LLC

Download Mobile App




Implantable Devices May Fail During Cancer Radiotherapy

By HospiMedica International staff writers
Posted on 12 Jul 2015
Print article
Patients with cardiac implantable electronic devices (CIEDs) may be at increased risk of device malfunction when undergoing radiotherapy (RT) for cancer, according to a new study.

Researchers at the University of Texas MD Anderson Cancer Center (Houston, USA) conducted a retrospective analysis of all patients with a functioning CIED who underwent RT between August 2005 and January 2014. They identified 249 courses of RT in 215 patients (57% with pacemakers and 43% with implantable cardioverter defibrillators (ICDs)). The main outcomes and measures were CIED malfunction, characterized as single-event upsets—data loss, parameter resets, unrecoverable resets—and delayed effects, including signal interference, pacing threshold changes, and premature battery depletion.

The results showed that malfunction of CIED attributable to RT occurred during 18 courses (7%), with 15 CIEDs experiencing single-event upsets, and three transient signal interference cases, for a total device compromise rate of 21%. All single-event upsets occurred during neutron-producing RT; no single-event upsets were found among 178 courses of non-neutron-producing RT. Patients treated to the abdomen and pelvis region were more likely to undergo a single-event upset. No delayed malfunctions were directly attributed to RT. The study was published online on June 25, 2015, in JAMA Oncology.

“In the absence of clinical benefit for higher-energy RT, the use of non-neutron-producing RT is recommended to avoid single-event upsets,” concluded lead author Jonathan Grant, MD, and colleagues of the department of radiation oncology. “If higher RT energies provide clinical benefit, however, the error rates and outcomes that we report will aid clinicians in weighing the risks of using neutron-producing RT.”

“Basically, these events represent device compromise due to a change in the memory state of the circuitry,” said Charles Thomas, Jr. MD, PhD, professor and chairman of the department of radiation medicine at Oregon Health and Science University (Portland, OR, USA), in an accompanying editorial. “There exists an opportunity to design trials that incorporate next-generation and commercially available electronic monitoring devices in this patient population to detect more subtle dysrhythmias, device sensor adjustments, and/or transient threshold alterations.”

Single-event upsets in CIEDs caused by high-energy radiation result when high-energy photons (over 10 MV) interact with materials in a linear accelerator, causing high-energy neutrons to be emitted throughout the treatment room. The neutrons interact thermally with boron atoms found in the metal oxide semiconductor components contained in contemporary CIEDs, causing disruptions in the electric currents.

Related Links:

University of Texas MD Anderson Cancer Center


Gold Member
Disposable Protective Suit For Medical Use
Disposable Protective Suit For Medical Use
Gold Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
Silver Member
Compact 14-Day Uninterrupted Holter ECG
NR-314P
New
Autoclavable Camera System
Precision AC

Print article

Channels

Critical Care

view channel
Image: A machine learning tool can identify patients with rare, undiagnosed diseases years earlier (Photo courtesy of 123RF)

Machine Learning Tool Identifies Rare, Undiagnosed Immune Disorders from Patient EHRs

Patients suffering from rare diseases often endure extensive delays in receiving accurate diagnoses and treatments, which can lead to unnecessary tests, worsening health, psychological strain, and significant... Read more

Patient Care

view channel
Image: The portable, handheld BeamClean technology inactivates pathogens on commonly touched surfaces in seconds (Photo courtesy of Freestyle Partners)

First-Of-Its-Kind Portable Germicidal Light Technology Disinfects High-Touch Clinical Surfaces in Seconds

Reducing healthcare-acquired infections (HAIs) remains a pressing issue within global healthcare systems. In the United States alone, 1.7 million patients contract HAIs annually, leading to approximately... Read more

Health IT

view channel
Image: First ever institution-specific model provides significant performance advantage over current population-derived models (Photo courtesy of Mount Sinai)

Machine Learning Model Improves Mortality Risk Prediction for Cardiac Surgery Patients

Machine learning algorithms have been deployed to create predictive models in various medical fields, with some demonstrating improved outcomes compared to their standard-of-care counterparts.... Read more

Point of Care

view channel
Image: The Quantra Hemostasis System has received US FDA special 510(k) clearance for use with its Quantra QStat Cartridge (Photo courtesy of HemoSonics)

Critical Bleeding Management System to Help Hospitals Further Standardize Viscoelastic Testing

Surgical procedures are often accompanied by significant blood loss and the subsequent high likelihood of the need for allogeneic blood transfusions. These transfusions, while critical, are linked to various... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.